» Articles » PMID: 20686702

The Prepared Tau Exon-specific Antibodies Revealed Distinct Profiles of Tau in CSF of the Patients with Creutzfeldt-Jakob Disease

Overview
Journal PLoS One
Date 2010 Aug 6
PMID 20686702
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The diagnostic value of CSF tau for Creutzfeldt-Jakob disease (CJD) has been widely evaluated, showing a markedly disease-relative manner. However, the profiles of tau isoforms in CSF of CJD patients remain unknown. Here, we prepared the exon-specific antibodies against the peptides encoded by exon-2, exon-3 and exon-10 of human tau protein and evaluated the reactive profiles of tau in CSF samples from the patients with probable CJD.

Methodology/principal Findings: Sequences encoding exon-2, exon-3 and exon-10 of human tau protein were cloned into a prokaryotic expression vector pGEX-2T. Using recombinant fusion proteins GST-E2, GST-E3 and GST-E10, three tau exon-specific antibodies were elicited. Reliable specificities of the prepared antibodies were obtained after a serial of purification processes, not only in recognizing the tau peptides encoded by exon-2, -3 and -10, but also in distinguishing six recombinant tau isoforms by Western blot and ELISA. Three predominant tau-specific bands were observed in CSF samples with the exon-specific and the commercial tau antibodies, respectively, showing different reactive profiles between the groups of probable CJD and non-CJD. A 65 KD band was detected only in the CSF samples from probable CJD patients, especially with the antibodies against exon-2 (Anti-tE2) and exon-10 (Anit-tE10). The appearances of 65 KD band in CSF correlated well with positive 14-3-3 in CSF and typical abnormality in EEG. Such band was not observed in the CSF samples of six tested genetic CJD patients.

Conclusions/significance: Three exon-specific polyclonal antibodies were successfully prepared. Based on these antibodies, different CSF tau profiles in Western blots were observed between the groups of probable CJD and non-CJD. A disease-specific tau band emerged in the CSF samples from probable sporadic CJD, which may supply a new biomarker for screening sporadic CJD.

Citing Articles

Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.

Yadikar H, Torres I, Aiello G, Kurup M, Yang Z, Lin F PLoS One. 2020; 15(7):e0224952.

PMID: 32692785 PMC: 7373298. DOI: 10.1371/journal.pone.0224952.


Profiles of 14-3-3 and Total Tau in CSF Samples of Chinese Patients of Different Genetic Prion Diseases.

Chen C, Hu C, Shi Q, Zhou W, Xiao K, Wang Y Front Neurosci. 2019; 13:934.

PMID: 31551692 PMC: 6737049. DOI: 10.3389/fnins.2019.00934.


Remarkable increases of α1-antichymotrypsin in brain tissues of rodents during prion infection.

Chen C, Xu X, Zhang R, Ma Y, Lv Y, Li J Prion. 2017; 11(5):338-351.

PMID: 28956708 PMC: 5639854. DOI: 10.1080/19336896.2017.1349590.


The Levels of Tau Isoforms Containing Exon-2 and Exon-10 Segments Increased in the Cerebrospinal Fluids of the Patients with Sporadic Creutzfeldt-Jakob Disease.

Chen C, Zhou W, Lv Y, Shi Q, Wang J, Xiao K Mol Neurobiol. 2015; 53(6):3999-4009.

PMID: 26188647 DOI: 10.1007/s12035-015-9348-2.


Global protein differential expression profiling of cerebrospinal fluid samples pooled from Chinese sporadic CJD and non-CJD patients.

Chen C, Xiao D, Zhou W, Shi Q, Zhang H, Zhang J Mol Neurobiol. 2013; 49(1):290-302.

PMID: 23912784 DOI: 10.1007/s12035-013-8519-2.


References
1.
Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P . Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2002; 58(2):192-7. DOI: 10.1212/wnl.58.2.192. View

2.
Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J . Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett. 1997; 225(3):210-2. DOI: 10.1016/s0304-3940(97)00215-2. View

3.
Satoh K, Shirabe S, Eguchi H, Tsujino A, Eguchi K, Satoh A . 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan. Cell Mol Neurobiol. 2006; 26(1):45-52. PMC: 11521384. DOI: 10.1007/s10571-006-9370-z. View

4.
Zerr I, Schulz-Schaeffer W, Giese A, Bodemer M, Schroter A, Henkel K . Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol. 2000; 48(3):323-9. View

5.
Szendrei G, Lee V, Otvos Jr L . Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location. J Neurosci Res. 1993; 34(2):243-9. DOI: 10.1002/jnr.490340212. View